← FDA Drug Approvals (Drugs@FDA)

ROSUVASTATIN CALCIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2019-04-24

Drug application

FDA Application #

ANDA206381

Application type

Abbreviated New Drug Application (Generic)

Brand name

ROSUVASTATIN CALCIUM

Generic name

ROSUVASTATIN

Active ingredients

ROSUVASTATIN CALCIUM

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

SCIEGEN PHARMS

Manufacturer

ScieGen Pharmaceuticals, Inc.

First approval

2019-04-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown